To further explore whether HDAC8 acts as a target of PDK4 in DLBCL, we first performed nuclear-cytoplasmic fractionation on sensitive cell lines and examined the binding of PDK4 and HDAC8 in both the nucleus and cytoplasm. The gene discussed is PDK4; the disease is diffuse large B-cell lymphoma.